Genetic Characterization of Human Influenza Viruses in the Pandemic (2009-2010) and Post-Pandemic (2010-2011) Periods in Japan

被引:39
作者
Dapat, Isolde C. [1 ]
Dapat, Clyde [1 ]
Baranovich, Tatiana [1 ]
Suzuki, Yasushi [1 ]
Kondo, Hiroki [1 ]
Shobugawa, Yugo [1 ]
Saito, Reiko [1 ]
Suzuki, Hiroshi [2 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata, Japan
[2] Niigata Seiryo Univ, Sch Nursing, Niigata, Japan
来源
PLOS ONE | 2012年 / 7卷 / 06期
关键词
A H1N1 VIRUS; HEMAGGLUTININ; NEURAMINIDASE; EMERGENCE; H3N2;
D O I
10.1371/journal.pone.0036455
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Pandemic influenza A(H1N1) 2009 virus was first detected in Japan in May 2009 and continued to circulate in the 2010-2011 season. This study aims to characterize human influenza viruses circulating in Japan in the pandemic and post-pandemic periods and to determine the prevalence of antiviral-resistant viruses. Methods: Respiratory specimens were collected from patients with influenza-like illness on their first visit at outpatient clinics during the 2009-2010 and 2010-2011 influenza seasons. Cycling probe real-time PCR assays were performed to screen for antiviral-resistant strains. Sequencing and phylogenetic analysis of the HA and NA genes were done to characterize circulating strains. Results and Conclusion: In the pandemic period (2009-2010), the pandemic influenza A(H1N1) 2009 virus was the only circulating strain isolated. None of the 601 A(H1N1) pdm09 virus isolates had the H275Y substitution in NA (oseltamivir resistance) while 599/601 isolates (99.7%) had the S31N substitution in M2 (amantadine resistance). In the post-pandemic period (2010-2011), cocirculation of different types and subtypes of influenza viruses was observed. Of the 1,278 samples analyzed, 414 (42.6%) were A(H1N1) pdm09, 525 (54.0%) were A(H3N2) and 33 (3.4%) were type-B viruses. Among A(H1N1) pdm09 isolates, 2 (0.5%) were oseltamivir-resistant and all were amantadine-resistant. Among A(H3N2) viruses, 520 (99.0%) were amantadine-resistant. Sequence and phylogenetic analyses of A(H1N1) pdm09 viruses from the post-pandemic period showed further evolution from the pandemic period viruses. For viruses that circulated in 2010-2011, strain predominance varied among prefectures. In Hokkaido, Niigata, Gunma and Nagasaki, A(H3N2) viruses (A/Perth/16/2009-like) were predominant whereas, in Kyoto, Hyogo and Osaka, A(H1N1) pdm09 viruses (A/New_York/10/2009-like) were predominant. Influenza B Victoria(HA)-Yamagata(NA) reassortant viruses (B/Brisbane/60/2008-like) were predominant while a small proportion was in Yamagata lineage. Genetic variants with mutations at antigenic sites were identified in A(H1N1) pdm09, A(H3N2) and type-B viruses in the 2010-2011 season but did not show a change in antigenicity when compared with respective vaccine strains.
引用
收藏
页数:12
相关论文
共 45 条
[1]  
[Anonymous], 2010, Wkly Epidemiol Rec, V85, P81
[2]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P453
[3]  
[Anonymous], 2011, Wkly Epidemiol Rec, V86, P86
[4]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P249
[5]   Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season [J].
Baranovich, Tatiana ;
Saito, Reiko ;
Suzuki, Yasushi ;
Zaraket, Hassan ;
Dapat, Clyde ;
Caperig-Dapat, Isolde ;
Oguma, Taeko ;
Shabana, Iman Ibrahim ;
Saito, Takehiko ;
Suzuki, Hiroshi .
JOURNAL OF CLINICAL VIROLOGY, 2010, 47 (01) :23-28
[6]   Reassortants in recent human influenza A and B isolates from South East Asia and Oceania [J].
Barr, IG ;
Komadina, N ;
Hurt, A ;
Shaw, R ;
Durrant, C ;
Iannello, P ;
Tomasov, C ;
Sjogren, H ;
Hampson, AW .
VIRUS RESEARCH, 2003, 98 (01) :35-44
[7]  
Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]
[8]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[9]  
BERTON MT, 1984, J VIROL, V52, P919, DOI 10.1128/JVI.52.3.919-927.1984
[10]  
Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467